Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.75 |
| ▸ | GNAI3 | P08754 | 6/20 | 0.59 |
| ▸ | GNAO1 | P09471 | 6/20 | 0.59 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.59 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1262658 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL11226591 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1262669 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL11210977 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL9641523 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL23682856 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1260762 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1277091 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL22151380 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL11224880 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4321247-A | Process for preparing sodium bicarbonate and hydrogen chloride | CHEMISCHE WERKE HULS AG (DE) | 1982-03-23 | — | — | US | claimed |
| US-4320106-A | Method for preparing sodium bicarbonate and hydrogen chloride | CHEMISCHE WERKE HULS AG (DE) | 1982-03-16 | — | — | US | claimed |
| JP-63301812-A | — | — | None | — | — | JP | disclosed |
| EP-3610868-B1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID DERIVATIVES AND THEIR MEDICAL USE | GRI BIO INC (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-115724827-A | Fused ring derivative inhibitor, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2023-03-03 | — | — | CN | disclosed |
| EP-3848014-A1 | WATER-SOLUBLE FULLERENE TOPICAL COMPOSITION | Beijing Fullcan Biotechnology Co., Ltd (CN) | 2021-07-14 | — | — | EP | disclosed |
| US-10829506-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | GRI BIO, INC. (US) | 2020-11-10 | — | — | US | disclosed |
| EP-3610868-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | GRI Bio, Inc. (US) | 2020-02-19 | — | — | EP | disclosed |
| EP-2809318-B1 | AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | GRI BIO INC (US) | 2019-05-08 | — | — | EP | disclosed |
| US-20180244703-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | ALTIUM GROWTH FUND, LP | 2018-08-30 | — | — | US | disclosed |
| US-9850265-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | GRI BIO, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-4320106-A | Method for preparing sodium bicarbonate and hydrogen chloride | CHEMISCHE WERKE HULS AG (DE) | 1982-03-16 | — | — | US | disclosed |
| EP-0027194-A1 | Process for producing sodium bicarbonate and hydrogen chloride | CHEMISCHE WERKE HÜLS AG (DE) | 1981-04-22 | — | — | EP | disclosed |
| EP-0027193-A1 | Process for producing sodium bicarbonate and hydrogen chloride | CHEMISCHE WERKE HÜLS AG (DE) | 1981-04-22 | — | — | EP | disclosed |
| US-4220764-A | Preparation of tertiary heterocyclic amines | UOP INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-4125413-A | Dispersion of polycyclic vat-dye pigment with N,N'-disubstituted diaminostilbene sulfonic acid fluidizing agent | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-11-14 | — | — | US | disclosed |
| US-4057554-A | CORROSION INHIBITORS | PETROLITE CORPORATION (US) | 1977-11-08 | — | — | US | disclosed |
| US-4005020-A | OXYALKYLATED AMINES-FATTY ALCOHOLS-ALKYLPHENOLS, CELLOSOLVE; FOR PETROLEUM SYSTEMS | PETROLITE CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-3995996-A | Agents for improving wet fastness properties | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180244703-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | AADAT, AASDHPPT, ASS1 | HRH3 77/4885GNAI3 3222/4885GNAO1 3219/4885 |
| US-10829506-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | AADAT, AASDHPPT, ASS1 | HRH3 77/4885GNAI3 3222/4885GNAO1 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.